← Back to all trials
Completed
NCT06248866
Effect Of Extracorporeal Shock Wave Therapy On Ultrasonography Changes In Patients With Palmar Fibromatosis: A Randomized Controlled Trial
Conditions: Palmar Fibromatosis
Sex: All
Ages: 18 Years – 70 Years
Healthy volunteers: No
Phase: NA
Enrollment: 60
Sponsor: Cairo University
Location: Outpatient clinic, ministry of health at sohag hospitals Sohag
Summary
this study will be conducted to investigate the effect of extracorporeal shock wave therapy on ultrasonography chnges In patients with palmar fibromatosis
Eligibility Criteria
Inclusion Criteria:
* Patients diagnosed with palmar fibromatosis.
* Adults aged 18 to 70 years.
* Patients of any stage of physiological change of the disease (nodules cords and contractures).
Exclusion Criteria:
* Patients with contraindications to extracorporeal shock wave therapy.
* Patients with a history of previous surgery for palmar fibromatosis.
* Patients with comorbidities or conditions that may affect the outcomes of the study.
* Patients of ganglions and palmar tendon fibrosis.
* Patients of sever and morbid obesity.
* End stage disease with psychological disturbance nature.
* Pregnant women.
* Cardiac and pulmonary unstable patients may affect results.
Source: ClinicalTrials.gov (NCT06248866). StuddyBuddy aggregates publicly available trial information.
